Dr. Rick Bright alleges he was reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Trump.
In a nationwide study of 368 patients in U.S. veterans hospitals, 28% who received hydroxychloroquine and usual care died, versus 11% of those getting only routine care.